OakChart

Integra Lifesciences Holdings Corp

IARTHealthcare·Medical Devices·USA·Small·NASD·Nov 13 • 7:15 AM ET

14.90+0.55 (3.83%)
2026-11-13 13:47 CET
Market cap
$1.16B
Revenue, TTM
1,656.79 USD m
Net income, TTM
13.01 USD m
Free cash flow, TTM
85.78 USD m
EPS diluted, TTM
0.16
Price / earnings
90.58
Compare

Price

IART against its 20, 50 and 200-day averages
Terms2050200Beat
Patternshover a marker to name it
RS 12Sales 422Price42244110.0012.5015.0017.5020.001.3M2.7MVolumeMay 26Jun 26Jul 26Aug 26Sep 26Oct 26Nov 26IARTclose 14.9020-day 13.3650-day 14.33200-day 14.1914.9052w high 20.4952-week range, not 6 months

27.3% under the 52-week high of 20.49 on 28 Jul 2026. 52-week low 8.70 on 20 Mar 2026. Last 15 sessions, 30.1% high to low

Volume 0.09× normal · the line is the 50-bar volume average

Setup. RS line 12
CANSLIM 3 of 6 — fails: EPS Growth This Year: High (>25%); 52-Week High/Low: 0-10% below High; Performance: Year +50%
VCP 5 of 6 — fails: 52-Week High/Low: 0-10% below High
Minervini 2 of 4 — fails: 52-Week High/Low: 0-10% below High; Performance: Year +50%
Zanger 4 of 5 — fails: Relative Volume: Over 1.5
Leaders 3 of 5 — fails: Performance: Year +50%; 52-Week High/Low: 0-10% below High
Breakout 2 of 4 — fails: 52-Week High/Low: New High; Relative Volume: Over 2
Growth 1 of 4 — fails: EPS Growth This Year: High (>25%); EPS Growth Next Year: High (>25%); Return on Equity: Over +15%
Quality 1 of 5 — fails: Return on Equity: Over +15%; Net Profit Margin: High (>20%); Debt/Equity: Low (<0.1); P/E: Under 25
Value 1 of 4 — fails: P/E: Under 15; Return on Equity: Over +15%; Debt/Equity: Low (<0.1)
Income 0 of 4 — fails: Dividend Growth: Growing 2+ Years; P/E: Under 25 — not on the tape: Dividend Yield: Over 2%; Payout Ratio: Low (<20%)
Small Cap 3 of 4 — fails: Performance: Year +50%
Accumulation 3 of 4 — fails: Institutional Transactions: Over +10%
Relative Strength 2 of 3 — fails: Performance: Year +100%

Profile

IART
52-week range, 53% of the way up
8.7020.49

Integra LifeSciences Holdings Corp. engages in the provision of regenerative tissue technologies and neurological solutions dedicated to limiting uncertainty for clinicians. It operates under the Codman Specialty Surgical (CSS) and Tissue Technologies (TT) segments. The CSS segment includes technologies and instrumentation used for neurosurgery, neurocritical care, and otolaryngology. The TT segment focuses on complex wound surgery, surgical reconstruction, and peripheral nerve repair. The company was founded by Richard E. Caruso in 1989 and is headquartered in Princeton, NJ.

IndexRUT
Employees4427
IPOAug 16, 1995
Beta1.27
ATR, 14d0.82
Rel volume0.09
Short float11.87%
Insider own14.48%
Inst own96.66%

Snapshot

6 groups

Valuation

IndexRUT
Market Cap$1.16B
Enterprise Value2.85B
Income13.01M
Sales1.66B
Book / share13.71
Cash / share4.01
Dividend Est.-
Dividend TTM-
Dividend Ex-Date-
Dividend Gr. 3/5Y- -
Payout-
Employees4427
IPOAug 16, 1995

Ratios

Price / earnings90.58
Forward price / earnings6.29
Price / earnings / growth1.82
Price / sales0.70
Price / book1.09
Price / cash3.72
Price / free cash flow13.51
Value / cash profit8.22
Value / sales1.72
Quick Ratio2.21
Current Ratio3.62
Debt / equity1.88
Long-term debt / equity1.82
Options and shortYes / Yes

Earnings

Earnings / share0.16
Earnings next year2.37
Earnings next quarter0.64
Earnings this year4.71%
Earnings next year1.49%
Earnings growth, 5 years3.46%
Past earnings growth- -
Past sales growth1.63% 3.57%
Earnings vs last year102.60%
Sales vs last year0.84%
Earnings vs last quarter368.47%
Sales vs last quarter2.27%
EarningsOct 21 BMO
Surprise5.85% -0.48%

Ownership

Insiders own14.48%
Insider trades0.00%
Institutions own96.66%
Institution trades-0.14%
Return on assets0.36%
Return on equity1.24%
Return on capital0.43%
Gross Margin54.85%
Operating margin11.63%
Profit Margin0.79%
20-day average11.49%
50-day average3.96%
200-day average5.02%

Technical

Shares out77.81M
Shares floating66.54M
Short / float11.87%
Short ratio7.74
Short interest7.90M
52-week high20.49 -27.3%
52-week low8.70 +71.3%
Volatility6.22% 6.04%
Average range0.82
Strength index57.70
Market sensitivity1.27
Relative volume0.09
Avg Volume1.02M
Volume4,356

Performance

Perf Week11.03%
Perf Month10.13%
Perf Quarter-15.63%
Perf Half Y5.67%
Perf YTD19.97%
Perf Year23.75%
Perf 3Y-59.29%
Perf 5Y-78.13%
Perf 10Y-62.59%
Recommendation2.75
Target Price15.67
Prev Close14.35
Price14.90
Change %3.83%

Analyst ratings

latest 10 of 20
DateActionAnalystRating changeTargetImplied
Jul 28, 2026InitiatedUBSNeutral$19+27.5%
Jul 09, 2026InitiatedBMO Capital MarketsMarket Perform$19+27.5%
Jun 18, 2026UpgradeArgusHold → Buy$25+67.8%
May 28, 2026UpgradeCitigroupSell → Neutral$16+7.4%
Apr 15, 2026DowngradeArgusBuy → Hold
Mar 31, 2025UpgradeArgusHold → Buy
Dec 02, 2024InitiatedMorgan StanleyUnderweight$25 → $20+34.2%
Oct 07, 2024UpgradeBTIG ResearchSell → Neutral
Jul 30, 2024DowngradeCitigroupNeutral → Sell$30 → $23+54.4%
Jul 30, 2024DowngradeBTIG ResearchNeutral → Sell$22+47.7%

Peers

Mkt cap
TickerCompanyMkt cap
SNNSmith & Nephew plc ADR13.02B
MDTMedtronic Plc129.81B
RCELAVITA Medical Inc397.44M
MDXGMimedx Group Inc472.80M
SYKStryker Corp120.30B
CLPTClearPoint Neuro Inc272.14M
CNMDConmed Corp1.50B
ORGOOrganogenesis Holdings Inc127.21M
AORTArtivion Inc942.67M
ANIKAnika Therapeutics Inc184.99M

Insider trading

3 filings
InsiderRelationshipDateTransactionCostSharesValueTotal heldForm
Singh HarvinderEVP & PRESIDENT, INTERNATIONALMar 11 '26Option Exercise0.0018,922040,612Mar 12 06:10 PM
Singh HarvinderEVP & PRESIDENT, INTERNATIONALMar 10 '26Option Exercise0.001,216023,152Mar 12 06:10 PM
Poul MojdehPresident & CEOJan 06 '26Option Exercise0.001,39001,390Jan 07 04:10 PM

Held by

AUM
TickerCompanyAUM
IJRiShares Core S&P Small-Cap ETFAUM: 107.13B
VTIVanguard Morningstar Total Stock Market ETFAUM: 696.31B
IWMiShares Russell 2000 Index FundAUM: 77.86B
VBVanguard Morningstar Small-Cap ETFAUM: 80.23B
DFSVUS Small Cap Value Portfolio ETF Class SharesAUM: 8.56B
VBRVanguard Morningstar Small-Cap Value ETFAUM: 37.88B
VXFVanguard Extended Market Index ETFAUM: 30.79B
IWNiShares Russell 2000 Value ETFAUM: 14.17B
SPSMState Street SPDR Portfolio S&P 600TM Small Cap ETFAUM: 16.19B
IJSiShares S&P Small-Cap 600 Value ETFAUM: 7.79B

News

latest 14 of 198
  • Integra LifeSciences to Present at the 2026 UBS Global Healthcare Conference (GlobeNewswire)
  • Integra LifeSciences to Highlight Hands-On Education and Neurosurgery Innovation at CNS 2026 Annual Meeting (GlobeNewswire)
  • Integra LifeSciences Edges Past EPS Consensus, But The Cincinnati Flood And Weak Tissue Reconstruction Drive A Guidance Reset (Earnings Whispers) -11.18%
  • Integra: Q3 Earnings Snapshot (Associated Press)
  • Integra LifeSciences Reports Third Quarter 2026 Financial Results (GlobeNewswire)
  • Integra Announces Completion of Refinancing Transactions (GlobeNewswire)
  • Integra LifeSciences to Highlight ENT and Instruments Portfolios and Sponsor New Clinical Research Presentations at AAO-HNSF 2026 Annual Meeting (GlobeNewswire)
  • Integra Announces Pricing of Senior Secured Notes (GlobeNewswire)
  • Integra LifeSciences to Host Third Quarter 2026 Financial Results Conference Call on October 21, 2026 (GlobeNewswire)
  • Nasdaq Hits Fresh Highs While Dow Slips and Small Caps Struggle for Direction (PR Newswire)
  • Integra LifeSciences lowers revenue and earnings outlook for 2026 (Proactive) -21.19%
  • Integra LifeSciences Announces Preliminary Third Quarter Results and Updates Full-Year 2026 Guidance (GlobeNewswire)
  • Integra LifeSciences Announces Launch of $600 Million Senior Secured Term Loan B (GlobeNewswire)
  • Integra LifeSciences Announces 100th Patient Enrolled in AERA Pediatric Registry (GlobeNewswire)

Quarterly earnings

2026Q3 EPS 0.590 beat 0.557, from 0.540 a year earlier. Sales 411.18 missed 413.16, from 402.06 a year earlier
EPS
0.97002024Q4 EPS 0.970 against 0.85424Q42025Q1 EPS 0.410 against 0.43125Q12025Q2 EPS 0.450 against 0.43625Q22025Q3 EPS 0.540 against 0.43425Q32025Q4 EPS 0.830 against 0.80025Q42026Q1 EPS 0.540 against 0.40526Q12026Q2 EPS 0.560 against 0.48126Q22026Q3 EPS 0.590 against 0.55726Q3
Sales, USD millions
445.1102024Q4 sales 442.65 against 445.1124Q42025Q1 sales 382.65 against 381.225Q12025Q2 sales 415.61 against 39525Q22025Q3 sales 402.06 against 414.2325Q32025Q4 sales 434.93 against 429.6325Q42026Q1 sales 391.92 against 381.8126Q12026Q2 sales 418.76 against 417.5426Q22026Q3 sales 411.18 against 413.1626Q3

The outline behind the bar is the estimate. The filled bar is the print. Green beat it, red missed it.

PeriodReportedEPS adjustedEPS estEPS reportedSales act, USD mSales est, USD mSurpriseYear-ago quarterAnalystsNext session
2026Q3ended 2026-09-302026-10-21 08:300.5900.5570.190411.18413.16EPS +5.8% · sales -0.5%vs 2025Q3, year-ago quarter · EPS +9.3% · sales +2.3%11Open -4.20% vs SPY +0.28%. Close -11.18% vs SPY +0.53%
2026Q2ended 2026-06-302026-07-29 08:300.5600.4810.057418.76417.54EPS +16.5% · sales +0.3%vs 2025Q2, year-ago quarter · EPS +24.4% · sales +0.8%11Open -6.33% vs SPY -0.12%. Close -16.55% vs SPY -1.54%
2026Q1ended 2026-03-312026-05-05 08:300.5400.405-0.060391.92381.81EPS +33.4% · sales +2.6%vs 2025Q1, year-ago quarter · EPS +31.7% · sales +2.4%8Open +14.84% vs SPY +0.52%. Close +24.13% vs SPY +0.80%
2025Q4ended 2025-12-312026-02-26 08:300.8300.800-0.022434.93429.63EPS +3.7% · sales +1.2%vs 2024Q4, year-ago quarter · EPS -14.4% · sales -1.7%9Open -8.37% vs SPY +0.02%. Close -2.24% vs SPY -0.56%
2025Q3ended 2025-09-302025-10-30 08:300.5400.434-0.070402.06414.23EPS +24.4% · sales -2.9%vs 2024Q3, year-ago quarter · EPS +31.7% · sales +5.6%9Open -1.30% vs SPY -0.51%. Close -23.46% vs SPY -1.10%
2025Q2ended 2025-06-302025-07-31 08:300.4500.436-6.312415.61395EPS +3.2% · sales +5.2%vs 2024Q2, year-ago quarter · EPS -28.6% · sales -0.6%10Open +5.90% vs SPY +0.79%. Close +6.22% vs SPY -0.38%
2025Q1ended 2025-03-312025-05-05 08:300.4100.431-0.331382.65381.2EPS -4.9% · sales +0.4%vs 2024Q1, year-ago quarter · EPS -25.5% · sales +3.7%10Open -12.58% vs SPY -0.74%. Close -21.19% vs SPY -0.57%
2024Q4ended 2024-12-312025-02-25 08:300.9700.8540.252442.65445.11EPS +13.6% · sales -0.6%vs 2023Q4, year-ago quarter · EPS +9.0% · sales +11.5%10Open -2.49% vs SPY -0.01%. Close +12.11% vs SPY -0.50%
2024Q3ended 2024-09-302024-11-04 08:300.4100.390-0.140380.83375.81EPS +5.1% · sales +1.3%vs 2023Q3, year-ago quarter · EPS -46.1% · sales -0.4%11Open +14.11% vs SPY +0.02%. Close +25.10% vs SPY -0.22%
2024Q2ended 2024-06-302024-07-29 08:300.6300.624-0.160418.18413.07EPS +1.0% · sales +1.2%vs 2023Q2, year-ago quarter · EPS -11.3% · sales +9.7%11Open -21.25% vs SPY +0.29%. Close -19.12% vs SPY +0.06%
2024Q1ended 2024-03-312024-05-06 08:300.5500.552-0.042368.87363.74EPS -0.4% · sales +1.4%vs 2023Q1, year-ago quarter · EPS -25.7% · sales -3.1%11Open +2.18% vs SPY +0.48%. Close -19.90% vs SPY +1.03%
2023Q4ended 2023-12-312024-02-28 08:300.8900.9030.253397.04399.34EPS -1.4% · sales -0.6%vs 2022Q4, year-ago quarter · EPS -5.3% · sales -0.2%11Open -7.00% vs SPY -0.32%. Close -12.65% vs SPY -0.13%
2023Q3ended 2023-09-302023-10-25 08:300.7600.7780.244382.42387.22EPS -2.4% · sales -1.2%vs 2022Q3, year-ago quarter · EPS -11.6% · sales -0.7%11 EPS · 10 sales-
2023Q2ended 2023-06-302023-07-26 16:300.7100.5690.052381.27374.01EPS +24.7% · sales +1.9%vs 2022Q2, year-ago quarter · EPS -13.4% · sales -4.2%9 EPS · 8 sales-
2023Q1ended 2023-03-312023-04-26 08:300.7400.7380.294380.85373.23EPS +0.3% · sales +2.0%vs 2022Q1, year-ago quarter · EPS 0.0% · sales +1.1%11 EPS · 10 sales-
2022Q4ended 2022-12-312023-02-22 08:300.9400.9040.633398.02397.92EPS +4.0% · sales +0.0%vs 2021Q4, year-ago quarter · EPS +11.9% · sales -1.8%11 EPS · 10 sales-

Annual earnings

2025FY EPS 2.230 beat 2.201, from 2.560 a year earlier. Sales 1,635 beat 1,630, from 1,611 a year earlier
EPS
3.36002018FY EPS 2.420 against 2.39120182019FY EPS 2.740 against 2.73820192020FY EPS 2.450 against 2.35420202021FY EPS 3.180 against 3.17720212022FY EPS 3.360 against 3.31320222023FY EPS 3.100 against 3.10720232024FY EPS 2.560 against 2.45220242025FY EPS 2.230 against 2.2012025
Sales, USD millions
1,63502018FY sales 1,472 against 1,47020182019FY sales 1,518 against 1,52020192020FY sales 1,372 against 1,37220202021FY sales 1,542 against 1,54020212022FY sales 1,558 against 1,55820222023FY sales 1,542 against 1,54420232024FY sales 1,611 against 1,61320242025FY sales 1,635 against 1,6302025

Reported years only. The outline behind the bar is the estimate. A later year with no print stays in the table.

earnings feed, not the snapshot. Not the statement ratio.

PeriodEPS adjustedEPS estEPS reportedSales act, USD mSales est, USD mP/E, earnings feed
2029FYestimate-3.000--1,8074.97
2028FYestimate-2.470--1,7346.03
2027FYestimate-2.370--1,6756.29
2026FYestimate-2.335--1,6446.38
2025FY2.2302.201-6.7401,6351,6305.57
2024FY2.5602.452-0.0901,6111,6138.86
2023FY3.1003.1070.8431,5421,54414.05
2022FY3.3603.3132.1621,5581,55816.69
2021FY3.1803.1771.9781,5421,54021.07
2020FY2.4502.3541.5711,3721,37226.50
2019FY2.7402.7380.5801,5181,52021.27
2018FY2.4202.3910.7241,4721,47018.64
2017FY1.9401.8580.8201,1881,17524.67
2016FY1.7601.7560.940992.08994.1224.37
2015FY1.5401.544-0.050882.73882.579.68
2014FY1.4801.4510.515928.31920.4610.07
2013FY1.2251.260-0.300836.21839.1812.16
2012FY1.5301.5370.720830.87832.569.74
2011FY1.3951.3790.475780.08778.6110.68
2010FY1.4851.3961.085732.07734.8510.03

Quarterly results

2026Q3 revenue 411.18, from 402.06 a year earlier. Operating margin 10.2%, from 6.4% a year earlier
Revenue, USD millions
442.6402024Q4 revenue 442.6424Q42025Q1 revenue 382.6525Q12025Q2 revenue 415.6125Q22025Q3 revenue 402.0625Q32025Q4 revenue 434.9325Q42026Q1 revenue 391.9226Q12026Q2 revenue 418.7626Q22026Q3 revenue 411.1826Q3
Operating margin
15.202024Q4 operating margin 14.2%24Q42025Q1 operating margin 8.9%25Q12025Q2 operating margin 8.6%25Q22025Q3 operating margin 6.4%25Q32025Q4 operating margin 15.2%25Q42026Q1 operating margin 10.2%26Q12026Q2 operating margin 10.6%26Q22026Q3 operating margin 10.2%26Q3

From the quarterly statement. Not an estimate.

Estimate revisions

Latest snapshot of each period and type. 2026FY E 2.34 per share.
PeriodTypeScaleDateMeanvs prior date
2026FYEper share2026-11-032.34-0.4%
2026Q4Eper share2026-10-230.64+0.4%
2026FYRper share2026-10-220.49-5.8%
2026Q4Rper share2026-10-220.30-4.2%
2026FYSUSD millions2026-10-221,644-0.1%
2026Q4S-2026-10-22422.37-0.4%
2026Q3Eper share2026-10-150.56-0.6%
2026Q3Rper share2026-10-150.15-1.6%
2026Q3S-2026-10-15413.16-0.3%
2026Q2Eper share2026-07-270.48-0.6%
2026Q2Rper share2026-07-270.03-67.2%
2026Q2S-2026-07-27417.540.0%
2026Q1Eper share2026-04-100.41+0.0%
2026Q1S-2026-04-10381.810.0%
2026Q1Rper share2026-02-270.14-16.7%
2025FYEper share2026-02-062.20+0.0%
2025Q4Eper share2026-02-060.800.0%
2025FYSUSD millions2026-02-051,630+0.0%
2025Q4S-2026-02-05429.630.0%
2025FYRper share2026-01-13-6.220.0%
2025Q4Rper share2026-01-130.480.0%
2025Q3Eper share2025-10-150.430.0%
2025Q3Rper share2025-10-140.130.0%
2025Q3S-2025-10-14414.230.0%
2025Q2S-2025-07-243950.0%
2025Q2Eper share2025-07-210.440.0%
2025Q2Rper share2025-07-190.060.0%
2025Q1S-2025-05-01381.23+0.0%
2025Q1Eper share2025-04-110.430.0%
2025Q1Rper share2025-04-100.02-22.3%
2024FYEper share2025-02-252.45+0.1%
2024Q4Eper share2025-02-250.85-0.2%
2024FYRper share2025-02-250.07-2221.2%
2024Q4Rper share2025-02-250.62+28.5%
2024FYSUSD millions2025-02-251,614+0.0%
2024Q4S-2025-02-25445.38+0.1%
2024Q3Eper share2024-10-160.390.0%
2024Q3S-2024-10-16375.810.0%
2024Q3Rper share2024-10-12-0.050.0%
2024Q2S-2024-07-25413.070.0%
2024Q2Eper share2024-07-200.620.0%
2024Q2Rper share2024-07-200.190.0%
2024Q1Eper share2024-05-030.550.0%
2024Q1S-2024-05-03363.74+0.5%
2024Q1Rper share2024-02-280.12-73.2%
2023FYEper share2024-02-213.110.0%
2023FYSUSD millions2024-02-211,544+0.0%
2023FYRper share2024-01-081.210.0%

Estimate history

Annual
Metric201720182019202020212022202320242025TTMMRQ
EPS per share0.820.7240.581.5711.9782.1620.843-0.09-6.7360.1645-
Sales USD millions1,1881,4721,5181,3721,5421,5581,5421,6111,6351,657-
Shares million shares788586848584787778-78
Quarterly
MetricQ3 '24Q4 '24Q1 '25Q2 '25Q3 '25Q4 '25Q1 '26Q2 '26Q3 '26
EPS per share-0.140.252-0.331-6.312-0.07-0.022-0.060.0570.189
Sales USD millions381443383416402435392419411
Shares million shares777778787878787878

Income statement, annual

USD millions, except where the row names a unit. The percent under a figure is against the same period a year earlier. TTM has no earlier TTM to compare with, and a ratio or a margin has no change.
MetricTTM2025FY12/31/20252024FY12/31/20242023FY12/31/20232022FY12/31/20222021FY12/31/20212020FY12/31/20202019FY12/31/20192018FY12/31/2018
Total Revenue1,656.791,635.24+1.5%1,610.53+4.5%1,541.57-1.0%1,557.67+1.0%1,542.45+12.4%1,371.87-9.6%1,517.56+3.1%1,472.44
Cost of Goods Sold Incl. D&A747.97773.39+8.7%711.77+9.9%647.37+2.8%629.61-4.0%655.84+16.6%562.48-8.2%612.45+9.7%558.09
Gross Profit908.82861.86-4.1%898.75+0.5%894.21-3.6%928.05+4.7%886.60+9.5%809.39-10.6%905.11-1.0%914.35
Selling, General and Administrative Excl. Other716.13679.60-5.1%715.99+13.0%633.54-3.3%655.25+7.2%611.08+2.5%595.95-8.8%653.41-3.8%679.50
Research and Development70.2734.81-36.0%54.43+29.8%41.94+1.3%41.42+14.3%36.23+16.2%31.17-5.8%33.08-57.6%78.04
Other Operating Expense0.000.000.00-100.0%40.030.000.000.000.000.00
Operating Income192.68182.26-0.3%182.76-17.2%220.63-19.1%272.81-1.0%275.52+29.1%213.44-15.2%251.70+7.2%234.85
Interest Expense110.4198.87+12.2%88.09+26.9%69.43+64.4%42.23+50.9%27.98-49.5%55.43-1.4%56.23-17.2%67.94
Unusual Expense106.12678.87+342.1%153.56+41.3%108.68+1035.6%9.57-2.01-102.2%89.94-42.1%155.44+24.7%124.64
Net Income Before Taxes22.31-563.50-18.24-122.5%81.07-62.1%213.89-0.4%214.68+129.6%93.52+55.6%60.10+4.7%57.40
Income Taxes9.30-47.03-11.29-184.7%13.33-60.0%33.34-26.9%45.60-40.37-507.8%9.90-3.40
Consolidated Net Income13.01-516.47-6.94-110.2%67.74-62.5%180.55+6.8%169.07+26.3%133.89+166.7%50.20-17.4%60.80
Net Income From Continuing Operations13.01-516.47-6.94-110.2%67.74-62.5%180.55+6.8%169.07+26.3%133.89+166.7%50.20-17.4%60.80
Net Income13.01-516.47-6.94-110.2%67.74-62.5%180.55+6.8%169.07+26.3%133.89+166.7%50.20-17.4%60.80
EPS (Recurring) per share1.11-0.54-141.2%1.31-26.8%1.79-20.1%2.24+14.3%1.96-15.2%2.31+25.5%1.84+4.5%1.76
EPS (Basic, Before Extraordinaries) per share0.17-6.74-0.09-110.6%0.85-61.0%2.18+9.0%2.00+26.6%1.58+167.8%0.59-19.2%0.73
EPS (Diluted) per share0.16-6.74-0.09-110.7%0.84-61.1%2.16+9.1%1.98+26.1%1.57+170.7%0.58-19.4%0.72
EBITDA346.52334.09+3.4%323.26-6.1%344.15-12.0%391.10-2.0%399.19+20.1%332.43-9.3%366.39+4.5%350.55
Non-Operating Income (Expense)46.1531.98-21.3%40.65+5.4%38.55-7.11-34.88-237.1%25.45+26.8%20.07+32.7%15.13
Other After Tax Adjustments0.000.000.000.000.000.000.000.000.00
Stock Option Compensation Expense16.6415.76-20.0%19.70+32.0%14.92+10.1%13.55-39.5%22.41+67.6%13.37+12.9%11.84+14.4%10.35
Price To Earnings Ratio ratio statement ratio, not the snapshot87.2387.23-35.6127.3033.8641.19100.6962.17
Price To Sales Ratio ratio0.770.581.082.273.013.714.033.322.57
Gross Margin %54.8552.7155.8058.0159.5857.4859.0059.6462.10
Operating Margin %11.6311.1511.3514.3117.5117.8615.5616.5915.95
Net Margin %0.79-31.58-0.434.3911.5910.969.763.314.13
Shares Outstanding million shares77.8177.89+0.9%77.17-1.3%78.17-6.6%83.65-1.2%84.70+0.4%84.34-1.8%85.87+0.8%85.16
Market Capitalization1,116.441,116.44-36.2%1,750.07-48.6%3,404.56-27.3%4,682.87-17.5%5,674.02+3.7%5,470.98+9.3%5,004.27+30.3%3,841.62

Income statement, quarterly

USD millions, except where the row names a unit. The percent under a figure is against the same period a year earlier. TTM has no earlier TTM to compare with, and a ratio or a margin has no change.
Metric2026Q39/30/20262026Q26/30/20262026Q13/31/20262025Q412/31/20252025Q39/30/20252025Q26/30/20252025Q13/31/20252024Q412/31/2024
Total Revenue411.18+2.3%418.76+0.8%391.92+2.4%434.93-1.7%402.06+5.6%415.61-0.6%382.65+3.7%442.64+11.5%
Cost of Goods Sold Incl. D&A186.57+6.0%188.98-0.3%167.68-2.1%204.73+7.2%175.95+5.7%189.61+10.9%171.23+7.7%190.95+18.7%
Gross Profit224.61-0.7%229.78+1.7%224.24+6.1%230.19-8.5%226.11+5.5%226.00-8.6%211.42+0.7%251.69+6.6%
Selling, General and Administrative Excl. Other182.54-8.8%185.25-2.7%184.15+13.3%164.19-13.0%200.26+5.1%190.40-3.5%162.48-7.2%188.67+16.8%
Research and Development22.11+8.3%21.74+1.4%18.69-11.9%7.74-42.0%20.42-22.4%21.45-14.3%21.22+0.1%13.35-29.0%
Other Operating Expense0.000.000.00-100.0%0.000.00-100.0%0.00-100.0%14.81+112.2%0.00-100.0%
Operating Income42.07+62.7%44.53+25.1%40.08+17.4%66.00+4.7%25.85+84.8%35.59+1.0%34.13+22.6%63.02-7.7%
Interest Expense27.44+0.3%27.33+21.6%26.84+32.6%28.80+30.6%27.35+16.3%22.48-5.1%20.24+7.4%22.05+16.9%
Unusual Expense14.27-3.3%25.24-95.4%29.54+27.2%37.07+14.3%14.76-67.3%550.27+1287.5%23.2232.42+1.0%
Net Income Before Taxes15.664.74-2.414.31-80.9%-6.82-530.95-30.0422.54-21.9%
Income Taxes0.810.262.216.01+93.2%-1.42-46.88-4.743.11-65.5%
Consolidated Net Income14.854.48-4.62-1.70-108.7%-5.40-484.07-25.2919.43-2.0%
Net Income From Continuing Operations14.854.48-4.62-1.70-108.7%-5.40-484.07-25.2919.43-2.0%
Net Income14.854.48-4.62-1.70-108.7%-5.40-484.07-25.2919.43-2.0%
EPS (Recurring) per share0.32+433.3%0.280.210.31-43.6%0.06-77.8%-1.29-745.0%-0.120.55+1.9%
EPS (Basic, Before Extraordinaries) per share0.190.06-0.06-0.02-108.0%-0.07-6.31-0.330.250.0%
EPS (Diluted) per share0.190.06-0.06-0.02-108.0%-0.07-6.31-0.330.250.0%
EBITDA81.13+26.2%82.66+12.8%78.51+10.1%104.21+3.7%64.27+28.7%73.29+1.7%71.31+22.1%100.51+1.7%
Non-Operating Income (Expense)15.31+62.2%12.78+106.1%13.894.17-70.2%9.44-72.5%6.20-51.9%-20.7013.99+20.9%
Other After Tax Adjustments0.000.000.000.000.000.000.000.00
Stock Option Compensation Expense2.29-48.1%4.71+11.6%3.98+170.7%5.66+1.3%4.41+27.5%4.22-26.9%1.47-66.8%5.59+22.6%
Price To Earnings Ratio ratio statement ratio, not the snapshot87.23-------
Price To Sales Ratio ratio0.770.850.440.590.670.581.041.09
Gross Margin %54.6354.8757.2252.9356.2454.3855.2556.86
Operating Margin %10.2310.6310.2315.186.438.568.9214.24
Net Margin %3.611.07-1.18-0.39-1.34-116.47-6.614.39
Shares Outstanding million shares77.810.0%77.78-0.2%77.82+0.1%77.89+0.9%77.83+0.9%77.92+0.4%77.71-1.3%77.17-1.3%
Market Capitalization1,116.440.0%1,397.23+46.5%734.17-56.8%967.42-44.7%1,116.46-20.8%953.53-58.5%1,698.04-38.8%1,750.07-48.6%

Balance sheet, annual

USD millions, except where the row names a unit. The percent under a figure is against the same period a year earlier. TTM has no earlier TTM to compare with, and a ratio or a margin has no change.
Metric2025FY12/31/20252024FY12/31/20242023FY12/31/20232022FY12/31/20222021FY12/31/20212020FY12/31/20202019FY12/31/20192018FY12/31/20182017FY12/31/2017
Cash & Short Term Investments263.74-3.6%273.57-11.5%309.10-32.3%456.66-11.1%513.45+9.2%470.17+136.4%198.91+43.3%138.84-20.6%174.94
Short Term Receivables285.69+4.9%272.37+5.0%259.33-5.2%273.59+12.5%243.24+4.4%232.96-18.0%283.98+5.2%269.93+7.2%251.80
Inventories492.74+14.8%429.09+10.1%389.61+20.0%324.58+2.3%317.39+2.3%310.12-1.9%316.05+12.7%280.35-5.4%296.33
Other Current Assets117.38+10.1%106.65+6.7%100.00-6.3%106.67+33.9%79.64-64.4%223.96+278.1%59.23-31.1%85.97-13.2%99.08
Total Current Assets1,159.54+7.2%1,081.68+2.2%1,058.04-8.9%1,161.50+0.7%1,153.72-6.7%1,237.20+44.2%858.17+10.7%775.08-5.7%822.15
Net Property, Plant & Equipment584.90+6.4%549.76+10.8%496.38+8.0%459.59+16.0%396.25+6.8%371.16-14.1%431.93+43.9%300.11+11.5%269.25
Total Investments and Advances12.78-66.6%38.30+19.0%32.18-25.7%43.34+568.8%6.480.00-100.0%3.46-51.4%7.120.00
Intangible Assets1,749.82-24.1%2,304.54+8.5%2,123.30-1.9%2,165.49+0.3%2,159.03+12.3%1,921.80-3.2%1,985.87-1.0%2,005.97-4.4%2,097.53
Deferred Tax Assets69.85+100.0%34.92-24.2%46.08+0.2%45.99-19.2%56.95-22.7%73.69+483.9%12.62+85.6%6.80+8.8%6.25
Other Assets25.10-11.0%28.21+8.5%26.01+87.8%13.85+39.1%9.96-11.7%11.28+0.9%11.18-12.6%12.79-20.5%16.08
Total Assets3,602.00-10.8%4,037.42+6.8%3,781.99-2.8%3,889.76+2.8%3,782.38+4.6%3,615.14+9.4%3,303.24+6.3%3,107.89-3.2%3,211.26
Short Term Debt Incl. Current Port. of LT Debt140.57-77.4%621.62+1984.6%29.82-43.5%52.75-11.7%59.77-62.4%159.07+177.9%57.25+154.4%22.50-62.5%60.00
Accounts Payable95.73+16.0%82.50-10.6%92.33-9.6%102.10+65.1%61.84+13.2%54.61-51.7%113.09+48.7%76.05-19.1%93.97
Income Tax Payable3.65--------
Other Current Liabilities216.03-0.9%218.01+17.9%184.84+11.3%166.06-24.0%218.41+16.6%187.34+16.4%160.97-1.8%164.00-15.9%194.94
Total Current Liabilities455.98-50.6%922.13+200.4%306.98-4.3%320.91-5.6%340.02-15.2%401.01+21.0%331.31+26.2%262.55-24.8%348.91
Long Term Debt1,892.62+38.9%1,362.95-17.5%1,651.87+5.7%1,562.61-1.8%1,591.51+6.4%1,496.34+6.8%1,400.57+5.2%1,331.71-25.2%1,781.14
Provision for Risks Charges13.84-10.4%15.44-20.3%19.38+57.4%12.310.000.000.00-100.0%21.67-2.0%22.11
Deferred Tax Liabilities5.66-90.7%60.83+72.2%35.32-44.2%63.34+38.3%45.79+182.8%16.19-55.7%36.55-36.7%57.78-11.3%65.13
Other Liabilities190.44+45.6%130.79-27.6%180.56+43.1%126.19+4.9%120.26-35.6%186.73+58.1%118.08+102.3%58.38+84.4%31.66
Total Liabilities2,558.54+2.7%2,492.14+13.6%2,194.10+5.2%2,085.36-0.6%2,097.58-0.1%2,100.27+11.3%1,886.50+8.9%1,732.09-23.0%2,248.95
Non-Equity Reserves0.000.000.000.000.000.000.000.000.00
Preferred Stock - Carrying Value0.000.000.000.000.000.000.000.000.00
Common Equity1,043.46-32.5%1,545.28-2.7%1,587.88-12.0%1,804.40+7.1%1,684.80+11.2%1,514.87+6.9%1,416.74+3.0%1,375.80+43.0%962.31
Total Shareholders Equity1,043.46-32.5%1,545.28-2.7%1,587.88-12.0%1,804.40+7.1%1,684.80+11.2%1,514.87+6.9%1,416.74+3.0%1,375.80+43.0%962.31
Accumulated Minority Interest0.000.000.000.000.000.000.000.000.00
Total Equity1,043.46-32.5%1,545.28-2.7%1,587.88-12.0%1,804.40+7.1%1,684.80+11.2%1,514.87+6.9%1,416.74+3.0%1,375.80+43.0%962.31
Total Liabilities & Stockholders Equity3,602.00-10.8%4,037.42+6.8%3,781.99-2.8%3,889.76+2.8%3,782.38+4.6%3,615.14+9.4%3,303.24+6.3%3,107.89-3.2%3,211.26
Book Value Per Share per share13.40-33.1%20.03-1.4%20.31-5.8%21.57+8.4%19.89+10.7%17.96+8.8%16.50+2.2%16.15+31.5%12.28
Tangible Book Value Per Share per share-9.07-9.84-6.85-4.32-5.60-4.83-6.63-7.40-14.48
Full-Time Employees people4,427+0.7%4,396-17.5%5,329+43.2%3,722-2.1%3,800+2.7%3,700-7.5%4,000-11.1%4,500+2.3%4,400
Price to Book Ratio ratio1.051.152.182.723.373.613.532.794.11
Return on Assets %-13.52-0.181.774.714.573.871.571.922.58
Return on Equity %-39.90-0.443.9910.3510.579.133.605.207.19
Return on Invested Capital %-17.59-0.242.095.365.164.451.782.252.36
Quick Ratio ratio1.460.712.182.612.462.311.641.881.51
Current Ratio ratio2.541.173.453.623.393.092.592.952.36

Cash flow, annual

USD millions, except where the row names a unit. The percent under a figure is against the same period a year earlier. TTM has no earlier TTM to compare with, and a ratio or a margin has no change.
MetricTTM2025FY12/31/20252024FY12/31/20242023FY12/31/20232022FY12/31/20222021FY12/31/20212020FY12/31/20202019FY12/31/20192018FY12/31/2018
Net Income13.01-516.47-6.94-110.2%67.74-62.5%180.55+6.8%169.07+26.3%133.89+166.7%50.20-17.4%60.80
Depreciation154.06151.83+7.8%140.89+14.1%123.51+4.4%118.30-4.3%123.67+3.9%118.99+3.9%114.52+3.4%110.73
Other Funds (Non Cash)21.49515.03+991.9%47.17+11.9%42.16+338.3%9.62+125.3%4.27-92.4%56.41-43.7%100.27+239.3%29.55
Funds from Operations175.3184.12-47.6%160.39-27.6%221.53-27.1%303.89+3.3%294.26+20.0%245.15-0.3%245.94+27.5%192.90
Extraordinary Item0.000.000.000.000.000.000.000.000.00
Changes in Working Capital-34.91-33.74-31.01-81.57-39.42-317.1%18.16-41.31-14.51-929.1%1.75
Cash from Operating Activities140.4050.38-61.1%129.38-7.6%139.96-47.1%264.47-15.4%312.43+53.3%203.83-11.9%231.43+18.9%194.65
Capital Expenditures-68.82-95.64-114.37-66.86-47.09-48.08-63.89-134.53-77.74
Net Assets From Acquisitions0.000.00-277.810.00-51.51-303.910.00-30.510.00
Sale of Fixed Assets and Businesses0.000.000.000.00-100.0%35.10-81.6%190.47+5104.1%3.66+9050.0%0.04-99.9%27.13
Purchase or Sale of Investments-23.98-1.50-127.3%5.50-32.690.000.000.000.000.00
Purchase of Investments-30.98-8.50-49.00-32.690.000.000.000.000.00
Sale Or Maturity of Investments7.007.00-87.2%54.500.000.000.000.000.000.00
Other Uses-10.49-10.92-4.130.000.000.00-7.840.000.00
Other Sources0.000.000.00-100.0%5.38+9.6%4.91+6037.5%0.080.00-100.0%2.34+157.1%0.91
Cash from Investing Activities-103.28-108.06-390.81-94.18-58.58-161.44-68.07-162.67-49.70
Cash Dividends Paid0.000.000.000.000.000.000.000.000.00
Change in Capital Stock0.760.74-46.07-270.68-119.53-1852.6%6.82-50.20-822.3%6.95-98.1%358.98
Repurchase of Common Pref Stock0.00-0.22-52.47-275.00-125.000.00-100.000.000.00
Sale of Common Pref Stock0.760.96-85.0%6.40+48.1%4.32-20.9%5.46-19.9%6.82-86.3%49.80+616.5%6.95-98.1%358.98
Proceedsfrom Stock Options0.000.000.000.000.000.00-100.0%44.560.00-100.0%349.59
Issuance or Reduction of Debt, Net-6.4646.75-84.4%299.37+542.1%46.62-107.80-100.25-135.7%281.15-9.20-488.80
Change in Long Term Debt-6.4646.75-84.4%299.37+542.1%46.62-107.80-100.25-135.7%281.15-9.20-488.80
Issuance of Long Term Debt145.09716.64+47.3%486.50+209.4%157.22+285.8%40.75+61.4%25.25-96.5%722.15+204.8%236.90+38.4%171.20
Reduction of Long Term Debt-151.55-669.89-187.13-110.60-148.55-125.50-441.00-246.10-660.00
Net Financing Active Other Cash Flow-8.77-19.15-15.43-5.86-24.62-4.80-109.32-6.51-46.02
Other Financing Activities Uses-8.77-19.15-15.43-5.86-24.62-4.80-109.32-6.51-46.02
Cash from Financing Activities-14.4728.34-88.1%237.86-229.93-251.95-98.23-180.8%121.62-8.77-175.84
Exchange Rate Effect-2.5718.02-6.46-266.1%3.89-10.72-9.48-168.3%13.87+19714.3%0.07-5.20
Net Change in Cash20.07-11.33-30.03-180.26-56.79-231.2%43.28-84.0%271.25+351.6%60.07-36.10
Free Cash Flow85.78-31.05-224.4%24.96-65.9%73.09-67.1%222.13-16.0%264.40+60.3%164.94+1.9%161.90+38.5%116.91
Preferred Dividends (Cash Flow)-0.000.000.000.000.000.000.000.00
Price to Free Cash Flow ratio14.91-69.9647.8721.0821.6633.5531.1432.41
Deferred Taxes & Investment Tax Credit--66.26-20.73-11.88-4.58-2.75-64.14-19.05-8.18

Balance sheet, quarterly

USD millions, except where the row names a unit. The percent under a figure is against the same period a year earlier. TTM has no earlier TTM to compare with, and a ratio or a margin has no change.
Metric2026Q39/30/20262026Q26/30/20262026Q13/31/20262025Q412/31/20252025Q39/30/20252025Q26/30/20252025Q13/31/20252024Q412/31/2024
Cash & Short Term Investments311.93+16.4%274.08+8.1%265.50-2.9%263.74-3.6%267.88-3.5%253.61-14.6%273.30-58.8%273.57-11.5%
Short Term Receivables248.99-5.0%267.19-6.1%271.07+7.4%285.69+4.9%262.16+2.4%284.51+2.4%252.45+1.6%272.37+5.0%
Inventories464.45-5.0%492.00+5.8%495.04+11.1%492.74+14.8%489.11+11.9%465.13+10.3%445.42+10.4%429.09+10.1%
Other Current Assets164.56+32.2%158.21+13.3%140.41+3.2%117.38+10.1%124.44-3.4%139.59+20.5%136.09+35.3%106.65+6.7%
Total Current Assets1,189.94+4.1%1,191.48+4.3%1,172.02+5.8%1,159.54+7.2%1,143.58+4.0%1,142.83+2.7%1,107.25-21.8%1,081.68+2.2%
Net Property, Plant & Equipment577.27+0.3%583.29+2.1%584.08+4.0%584.90+6.4%575.55+7.1%571.39+9.7%561.38+12.9%549.76+10.8%
Total Investments and Advances6.34-59.2%9.65-47.8%12.15-54.9%12.78-66.6%15.54-41.3%18.50-59.8%26.93-38.0%38.30+19.0%
Intangible Assets1,648.46-7.1%1,686.69-6.5%1,718.59-25.0%1,749.82-24.1%1,775.34-23.7%1,804.51-22.4%2,292.92+11.2%2,304.54+8.5%
Deferred Tax Assets66.71-39.2%70.44-31.6%68.08+79.1%69.85+100.0%109.73+124.2%102.94+125.0%38.01+11.2%34.92-24.2%
Other Assets19.07-28.6%21.94-20.9%22.81-13.1%25.10-11.0%26.71-3.0%27.74+11.8%26.26+5.4%28.21+8.5%
Total Assets3,507.80-3.8%3,563.49-2.8%3,577.73-11.7%3,602.00-10.8%3,646.45-10.3%3,667.91-10.0%4,052.75-0.6%4,037.42+6.8%
Short Term Debt Incl. Current Port. of LT Debt63.03+19.9%57.51-90.8%52.68-91.6%140.57-77.4%52.58-91.5%627.55+1516.1%626.82+1656.8%621.62+1984.6%
Accounts Payable66.42-28.0%82.64-11.0%87.95-3.7%95.73+16.0%92.31+18.8%92.83-13.6%91.30-3.3%82.50-10.6%
Income Tax Payable1.703.243.243.65----
Other Current Liabilities197.85-9.7%187.49-10.5%202.98+1.3%216.03-0.9%219.17+0.4%209.42+15.1%200.34+16.3%218.01+17.9%
Total Current Liabilities329.00-9.6%330.88-64.4%346.85-62.2%455.98-50.6%364.05-60.1%929.81+183.2%918.45+203.7%922.13+200.4%
Long Term Debt1,939.24-0.7%1,991.37+43.7%1,986.77+42.7%1,892.62+38.9%1,953.28+42.3%1,386.21-29.7%1,392.12-30.6%1,362.95-17.5%
Provision for Risks Charges0.000.000.0013.84-10.4%0.000.000.0015.44-20.3%
Deferred Tax Liabilities4.79-91.8%3.47-94.2%6.14-89.3%5.66-90.7%58.28-15.5%60.06-30.6%57.58+83.2%60.83+72.2%
Other Liabilities168.14-27.9%194.40-23.2%195.56+21.9%190.44+45.6%233.25+22.9%253.16+63.5%160.46+14.8%130.79-27.6%
Total Liabilities2,441.18-6.4%2,520.11-4.2%2,535.32+0.3%2,558.54+2.7%2,608.88+2.5%2,629.24+3.5%2,528.61+1.9%2,492.14+13.6%
Non-Equity Reserves0.000.000.000.000.000.000.000.00
Preferred Stock - Carrying Value0.000.000.000.000.000.000.000.00
Common Equity1,066.62+2.8%1,043.38+0.5%1,042.41-31.6%1,043.46-32.5%1,037.57-31.8%1,038.66-32.3%1,524.14-4.6%1,545.28-2.7%
Total Shareholders Equity1,066.62+2.8%1,043.38+0.5%1,042.41-31.6%1,043.46-32.5%1,037.57-31.8%1,038.66-32.3%1,524.14-4.6%1,545.28-2.7%
Accumulated Minority Interest0.000.000.000.000.000.000.000.00
Total Equity1,066.62+2.8%1,043.38+0.5%1,042.41-31.6%1,043.46-32.5%1,037.57-31.8%1,038.66-32.3%1,524.14-4.6%1,545.28-2.7%
Total Liabilities & Stockholders Equity3,507.80-3.8%3,563.49-2.8%3,577.73-11.7%3,602.00-10.8%3,646.45-10.3%3,667.91-10.0%4,052.75-0.6%4,037.42+6.8%
Book Value Per Share per share13.71+2.9%13.41+0.6%13.40-31.7%13.40-33.1%13.33-32.4%13.33-32.6%19.61-3.4%20.03-1.4%
Tangible Book Value Per Share per share-7.48-8.27-8.69-9.07-9.48-9.83-9.89-9.84
Full-Time Employees people---4,427+0.7%---4,396-17.5%
Price to Book Ratio ratio1.051.340.700.931.070.631.101.15
Return on Assets %0.36-0.20-13.00-13.52-12.85-12.93-0.71-0.18
Return on Equity %1.24-0.70-38.64-39.90-38.71-38.92-1.85-0.44
Return on Invested Capital %0.490.15-0.15-0.06-0.18-19.96-0.870.67
Quick Ratio ratio2.212.111.951.461.800.730.720.71
Current Ratio ratio3.623.603.382.543.141.231.211.17

Cash flow, quarterly

USD millions, except where the row names a unit. The percent under a figure is against the same period a year earlier. TTM has no earlier TTM to compare with, and a ratio or a margin has no change.
Metric2026Q39/30/20262026Q26/30/20262026Q13/31/20262025Q412/31/20252025Q39/30/20252025Q26/30/20252025Q13/31/20252024Q412/31/2024
Net Income14.854.48-4.62-1.70-108.7%-5.40-484.07-25.2919.43-2.0%
Depreciation39.06+1.4%38.13+1.2%38.43+3.3%38.43+2.2%38.52+7.1%37.69+2.5%37.19+21.7%37.59+21.3%
Other Funds (Non Cash)4.1710.64-97.9%5.29+58.9%1.39-89.0%-7.86-373.9%518.16+2960.6%3.33-77.3%12.690.0%
Funds from Operations58.79+253.9%48.93+81.6%40.43+201.7%27.16-56.7%16.61-13.0%26.95-31.7%13.40-65.7%62.73+28.9%
Extraordinary Item0.000.000.000.000.000.000.000.00
Changes in Working Capital37.19+53.0%-26.13-30.62-15.3524.30+616.8%-18.03-2018.1%-24.65-11.99-218.8%
Cash from Operating Activities95.98+134.6%22.80+155.6%9.8011.82-76.7%40.91+82.0%8.92-77.9%-11.26-171.4%50.74-13.6%
Capital Expenditures-10.25-12.31-14.85-31.42-15.16-20.15-28.92-39.55
Net Assets From Acquisitions0.000.000.000.00-100.0%--0.004.18
Sale of Fixed Assets and Businesses0.000.000.000.00--0.000.00
Purchase or Sale of Investments0.00-30.980.007.00-80.1%0.00-100.0%-1.50-7.0035.25
Purchase of Investments0.00-30.980.000.000.00-1.50-7.000.00
Sale Or Maturity of Investments0.000.000.007.00-80.1%0.00-100.0%0.000.0035.25
Other Uses0.000.000.00-10.49-0.430.000.00-4.13
Other Sources0.000.000.000.000.000.000.000.00
Cash from Investing Activities-10.25-43.28-14.85-34.91-15.59-21.65-35.92-4.25
Cash Dividends Paid0.000.000.000.000.000.000.000.00
Preferred Dividends (Cash Flow)0.000.000.000.000.000.000.000.00
Change in Capital Stock0.000.000.76-20.8%0.000.00-0.220.96-85.0%-2.47-1173.9%
Repurchase of Common Pref Stock0.000.000.000.000.00-0.220.00-2.47
Sale of Common Pref Stock0.000.000.76-20.8%0.000.000.000.96-85.0%0.00-100.0%
Proceedsfrom Stock Options0.000.000.000.000.000.000.000.00
Issuance or Reduction of Debt, Net-46.096.248.91-77.2%24.48-10.05-6.8439.16-89.0%-4.54
Change in Long Term Debt-46.096.248.91-77.2%24.48-10.05-6.8439.16-89.0%-4.54
Issuance of Long Term Debt19.90-96.7%31.12+244.2%44.50-18.2%49.57+40.0%603.62+2668.9%9.04-84.6%54.40-85.3%35.40+97.8%
Reduction of Long Term Debt-65.99-24.89-35.59-25.09-613.67-15.89-15.24-39.94
Net Financing Active Other Cash Flow-0.20-7.06-1.38-0.14-0.20-14.08-4.74-0.14
Other Financing Activities Uses-0.20-7.06-1.38-0.14-0.20-14.08-4.74-0.14
Cash from Financing Activities-46.29-0.828.30-76.5%24.34-10.24-21.1435.38-90.1%-7.15
Exchange Rate Effect-1.60-1.09-108.6%-1.49-132.9%1.61-0.80-110.3%12.684.53-8.12-201.0%
Net Change in Cash37.85+165.2%-22.391.762.86-90.8%14.27-21.19-7.27-102.3%31.22+1069.3%
Free Cash Flow85.73+232.9%10.49-5.04-5.40-125.5%25.75-11.23-205.1%-40.18-13955.2%21.14-38.2%
Price to Free Cash Flow ratio14.9154.41177.67----70.11

Revenue breakdown

USD millions, so a column adds up to the income statement. Share is of the latest year in that split. The change is versus the older year shown, not TTM.

Product
Name20242025vs 20242025 share
ENT135.64166.37+22.7%10.2%
Instruments204.18206.47+1.1%12.6%
Neurosurgery803.82827.67+3.0%50.6%
Private Label116.33111.25-4.4%6.8%
Regenerative Skin And Wound350.57323.49-7.7%19.8%
Total1,610.531,635.25+1.5%100.0%
Region
Name20242025vs 20242025 share
Asia Pacific176.61189.25+7.2%11.6%
Europe158.50162.67+2.6%9.9%
Rest Of The World82.7478.58-5.0%4.8%
United States1,192.681,204.75+1.0%73.7%
Total1,610.531,635.25+1.5%100.0%
Segment
Name20242025vs 20242025 share
Codman Specialty Surgical1,143.641,200.51+5.0%73.4%
Tissue Technologies466.89434.73-6.9%26.6%
Total1,610.531,635.25+1.5%100.0%

Short interest

shares short against float, oldest to newest
SettlementOf floatShares shortFloatAvg volume
2026-10-3011.87%7.9M66.5M950.07K
2026-10-1511.00%7.3M66.5M929.58K
2026-09-3010.93%7.3M66.5M848.62K
2026-09-1510.23%6.8M66.5M870.51K
2026-08-3110.31%6.9M66.5M871.73K
2026-08-1410.13%6.7M66.6M944.11K
2026-07-319.73%6.5M66.6M1.09M
2026-07-159.32%6.2M66.6M1.02M
2026-06-309.61%6.4M66.6M1.00M
2026-06-1510.86%7.2M66.5M957.93K
2026-05-2912.00%8.0M66.6M970.21K
2026-05-1513.83%9.2M66.6M945.65K
2026-04-3014.02%9.3M66.5M803.75K
2026-04-1513.76%9.2M66.6M799.11K
2026-03-3113.28%8.9M66.7M785.30K
2026-03-1312.54%8.4M66.7M758.88K
2026-02-2711.21%7.5M66.7M736.18K
2026-02-1311.39%7.6M66.6M754.43K
2026-01-3011.58%7.6M65.9M848.88K
2026-01-1511.28%7.4M65.9M944.93K

Option chain

Expiry 2026-11-20 · underlying 14.90, quoted 13 Nov 07:15 ET · ATM 15.00

Option quotes 11 Nov 11:04 ET. A date on a row is older than the last session (12 Nov). 22 rows.

Implied move 13.42% into expiry (call 0.650 + put 1.350 = 2.000 on 14.90)

Put/call open interest 1.57 (83 puts / 53 calls) · Put/call volume — no calls

IV change is points against the prior close.

TypeStrikeMoneyBidAskLastChgIVOpen intVolumeLast sizeDeltaThetaVega
call 1 Jan2.50ITM9.6013.800.000.00-0000.992-0.0190.000
put 1 JanOTM0.000.050.000.00587.9% 0.0000-0.008-0.0170.001
call 1 Jan5.00ITM7.9010.600.000.00922.2% +103.20000.930-0.1470.003
put 1 JanOTM0.000.950.000.00819.0% 0.0000-0.070-0.1470.003
call 1 Jan7.50ITM5.808.100.000.00621.6% -151.50000.873-0.2170.004
put 1 JanOTM0.002.800.000.00772.8% 0.0000-0.127-0.2160.004
call 1 Jan10.00ITM3.405.600.000.00421.2% -114.60000.803-0.2000.006
put 16 OctOTM0.002.600.100.00535.8% 0.04700-0.197-0.1990.006
call 11 Nov12.50ITM1.552.102.000.00111.4% -241.216000.701-0.1650.007
put 6 NovOTM0.001.900.500.00352.5% 0.02500-0.299-0.1640.007
call 4 Nov15.00ATM0.001.300.630.00187.1% -25.321000.506-0.1140.008
put 24 SepATM0.002.701.200.00278.2% +65.81100-0.494-0.1130.008
call 20 Oct17.50OTM0.001.000.150.00241.2% 0.015000.351-0.1200.008
put 1 JanITM1.904.600.000.00299.3% +58.1000-0.649-0.1190.008
call 20 Oct20.00OTM0.000.950.030.00299.1% 0.01000.296-0.1390.007
put 1 JanITM3.907.000.000.00354.3% +55.2000-0.704-0.1370.007
call 1 Jan22.50OTM0.000.750.000.00279.3% 0.00000.186-0.1010.006
put 1 JanITM6.909.300.000.00381.1% +101.8000-0.814-0.0980.006
call 1 Jan25.00OTM0.003.400.000.00318.6% 0.00000.170-0.1080.005
put 1 JanITM9.1011.800.000.00425.2% +106.5000-0.830-0.1060.005
call 1 Jan30.00OTM0.003.400.000.00382.6% 0.00000.151-0.1200.005
put 1 JanITM13.9017.400.000.00579.5% +196.8000-0.849-0.1170.005

Latest SEC filings

30 of 978
AllAll annual, quarterly, and current reportsInsider equity awards, transactions, and ownership (Section 16 Reports)Beneficial ownership reportsExempt offeringsRegistration statements and prospectusesFiling review correspondenceSEC orders and noticesProxy materialsTender offers and going private transactionsTrust indenture filings

10-Q filed 2026-10-23, period ended 2026-09-30. 10-K filed 2026-02-26, period ended 2025-12-31. IART on EDGAR

page 1 of 33Next →
FiledFormDescriptionPeriodDocument
2026-11-10SCHEDULE 13GBeneficial ownership reportsno report period0000914208-26-000418 index
2026-10-2310-QAll annual, quarterly, and current reports2026-09-300000917520-26-000077 index
2026-10-218-KAll annual, quarterly, and current reports2026-10-210000917520-26-000073 index
2026-10-198-KAll annual, quarterly, and current reports2026-10-190001193125-26-425271 index
2026-10-133Insider equity awards, transactions, and ownership (Section 16 Reports)2026-10-010002159797-26-000003 index
2026-10-098-KAll annual, quarterly, and current reports2026-10-090001193125-26-419228 index
2026-10-028-KAll annual, quarterly, and current reports2026-10-020000917520-26-000067 index
2026-09-283Insider equity awards, transactions, and ownership (Section 16 Reports)2026-09-170002155922-26-000002 index
2026-09-088-KAll annual, quarterly, and current reports2026-09-080000917520-26-000061 index
2026-09-044Insider equity awards, transactions, and ownership (Section 16 Reports)2026-09-01 · transaction0001990905-26-000004 index
2026-08-13SCHEDULE 13G/ABeneficial ownership reportsno report period0001037792-26-000013 index
2026-07-31SCHEDULE 13GBeneficial ownership reportsno report period0002100121-26-000945 index
2026-07-2910-QAll annual, quarterly, and current reports2026-06-300000917520-26-000058 index
2026-07-298-KAll annual, quarterly, and current reports2026-07-290000917520-26-000055 index
2026-07-064Insider equity awards, transactions, and ownership (Section 16 Reports)2026-07-03 · transaction0001983748-26-000003 index
2026-07-064Insider equity awards, transactions, and ownership (Section 16 Reports)2026-07-01 · transaction0001949782-26-000003 index
2026-07-064Insider equity awards, transactions, and ownership (Section 16 Reports)2026-07-01 · transaction0001719686-26-000003 index
2026-07-064Insider equity awards, transactions, and ownership (Section 16 Reports)2026-07-01 · transaction0001563606-26-000003 index
2026-06-034Insider equity awards, transactions, and ownership (Section 16 Reports)2026-06-01 · transaction0001814943-26-000003 index
2026-06-034Insider equity awards, transactions, and ownership (Section 16 Reports)2026-06-01 · transaction0001187574-26-000008 index
2026-05-29SDAll annual, quarterly, and current reportsno report period0000917520-26-000049 index
2026-05-15SCHEDULE 13GBeneficial ownership reportsno report period0001037792-26-000009 index
2026-05-114Insider equity awards, transactions, and ownership (Section 16 Reports)2026-05-07 · transaction0001939584-26-000001 index
2026-05-114Insider equity awards, transactions, and ownership (Section 16 Reports)2026-05-07 · transaction0001857606-26-000001 index
2026-05-114Insider equity awards, transactions, and ownership (Section 16 Reports)2026-05-07 · transaction0001251036-26-000011 index
2026-05-114Insider equity awards, transactions, and ownership (Section 16 Reports)2026-05-07 · transaction0001235676-26-000001 index
2026-05-114Insider equity awards, transactions, and ownership (Section 16 Reports)2026-05-07 · transaction0001214496-26-000001 index
2026-05-114Insider equity awards, transactions, and ownership (Section 16 Reports)2026-05-07 · transaction0001188650-26-000001 index
2026-05-08S-8Registration statements and prospectusesno report period0000917520-26-000046 index
2026-05-088-KAll annual, quarterly, and current reports2026-05-070000917520-26-000044 index

Insider activity by month

MonthBoughtBuysSoldSells
2026-110000
2026-100000
2026-090000
2026-080000
2026-070000
2026-060000
2026-050000
2026-040000
2026-030000
2026-020000
2026-010000
2025-120000
2025-11102.15K100

Institutional holders

Manager% owned
BlackRock, Inc.13.73%
Rubric Capital Management LP9.97%
Invesco Ltd.5.35%
VANGUARD PORTFOLIO MANAGEMENT LLC4.81%
MORGAN STANLEY4.62%
PARADIGM CAPITAL MANAGEMENT INC/NY4.42%
FULLER & THALER ASSET MANAGEMENT, INC.4.42%
STATE STREET CORP3.88%
VANGUARD CAPITAL MANAGEMENT LLC3.79%
DIMENSIONAL FUND ADVISORS LP3.56%

Funds

Fund% owned
iShares Core S&P Small-Cap ETF5.18%
Invesco Small Cap Value Fund4.36%
Undiscovered Managers Behavioral Value Fund3.63%
VANGUARD TOTAL STOCK MARKET INDEX FUND2.71%
iShares Russell 2000 ETF2.29%
VANGUARD SMALL-CAP INDEX FUND1.95%
VANGUARD SMALL-CAP VALUE INDEX FUND1.23%
Small Cap Equity Portfolio1.08%
VANGUARD EXTENDED MARKET INDEX FUND0.99%
Fidelity Small Cap Index Fund0.96%

OakChart. IART. Cached 15 minutes. Terms